Cammarota, Giovanni
 Distribuzione geografica
Continente #
EU - Europa 11.112
NA - Nord America 8.232
AS - Asia 3.160
SA - Sud America 39
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 31
OC - Oceania 23
Totale 22.628
Nazione #
US - Stati Uniti d'America 8.136
DE - Germania 5.049
SE - Svezia 1.477
CN - Cina 1.428
IT - Italia 1.297
SG - Singapore 871
UA - Ucraina 816
FR - Francia 493
GB - Regno Unito 467
IE - Irlanda 459
PL - Polonia 315
ID - Indonesia 311
FI - Finlandia 239
RU - Federazione Russa 194
IN - India 192
TR - Turchia 140
BE - Belgio 83
CA - Canada 72
JP - Giappone 56
NL - Olanda 50
ES - Italia 38
HK - Hong Kong 32
CH - Svizzera 31
IR - Iran 31
CZ - Repubblica Ceca 27
EU - Europa 27
BR - Brasile 22
AU - Australia 21
AT - Austria 15
VN - Vietnam 15
KR - Corea 13
MX - Messico 13
LT - Lituania 12
RO - Romania 12
IL - Israele 11
PK - Pakistan 11
CI - Costa d'Avorio 10
TN - Tunisia 10
TW - Taiwan 10
PT - Portogallo 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
HR - Croazia 5
BZ - Belize 4
CO - Colombia 4
HU - Ungheria 4
LK - Sri Lanka 4
NO - Norvegia 4
PH - Filippine 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CY - Cipro 3
DZ - Algeria 3
GR - Grecia 3
RS - Serbia 3
ZA - Sudafrica 3
AL - Albania 2
AR - Argentina 2
BY - Bielorussia 2
CR - Costa Rica 2
EG - Egitto 2
IQ - Iraq 2
KW - Kuwait 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
SC - Seychelles 2
YE - Yemen 2
A1 - Anonimo 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BH - Bahrain 1
CU - Cuba 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GE - Georgia 1
GL - Groenlandia 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
MC - Monaco 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 22.628
Città #
Chandler 1.774
Ashburn 680
Singapore 661
Jacksonville 482
Dublin 456
San Mateo 381
Nürnberg 378
Ann Arbor 359
Jakarta 309
Nanjing 298
Woodbridge 229
Wilmington 224
Warsaw 222
Boston 199
Cattolica 186
Milan 169
Dearborn 167
New York 167
Marseille 166
Rome 155
Princeton 152
Fairfield 136
Munich 136
Izmir 129
Moscow 126
Redwood City 124
Seattle 121
Beijing 115
Houston 114
Nanchang 112
Lawrence 88
Brussels 76
Kraków 75
Shenyang 73
Boardman 68
Hangzhou 68
Fuzhou 67
Los Angeles 66
Helsinki 65
Redmond 59
Bremen 56
Hebei 56
Verona 55
Mountain View 54
Lancaster 53
Shanghai 53
Leawood 52
Chicago 51
Kunming 47
Zhengzhou 47
Pune 44
University Park 44
Tianjin 43
Changsha 41
Guangzhou 41
Cambridge 40
Norwalk 37
Fremont 36
Las Vegas 36
London 35
Jiaxing 32
Augusta 29
Falls Church 29
Jinan 24
Toronto 22
Ottawa 20
Detroit 19
Paris 19
Washington 18
Hong Kong 17
Kish 16
Andover 15
Edinburgh 15
Frankfurt am Main 15
San Jose 15
Lanzhou 14
Costa Mesa 13
Ningbo 13
Simi Valley 13
Brno 12
Phoenix 12
San Francisco 12
Busto Arsizio 11
Chengdu 11
Hefei 11
Melbourne 11
San Diego 11
Vienna 11
Abidjan 10
Lappeenranta 10
Parma 10
Taizhou 10
Tokyo 10
Trieste 10
Zurich 10
Genoa 9
Hanoi 9
Indiana 9
Seoul 9
Xian 9
Totale 11.128
Nome #
-Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth 450
A case-control study comparing methylene blue directed biopsies and random biopsies for detecting pre-cancerous lesions in the follow-up of gastric cancer patients 383
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns 378
Small intestinal bacterial overgrowth recurrence after antibiotic therapy 363
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 296
gc) Water-immersion technique during standard upper endoscopy may be useful to drive the biopsy sampling of duodenal mucosa in children with celiac disease. 254
A) Lack of endoscopic visualization of intestinal villi with the "immersion technique" in overt atrophic celiac disease 211
ag)Association between hypothyroidism and small intestinal bacterial overgrowth 203
Wheat desensitization treatment in patients with gluten sensitivity 201
High accuracy and cost-effectiveness of a biopsy-avoiding endoscopic approach in diagnosing coeliac disease. 198
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 197
A highly accurate method for monitoring histological recovery in patients with celiac disease on a gluten-free diet using an endoscopic approach that avoids the need for biopsy: a double-center study 190
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 185
gc) Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. 179
gc) Patchy left-sided colitis: primary eosinophilic colitis or paraneoplastic syndrome ? 179
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy 176
-High prevalence of celiac disease in patients with lactose intolerance 175
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study 173
Gut microbiota in anxiety and depression: Pathogenesis and therapeutics 172
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 161
GC)Optimal band imaging system: a new tool for enhancing the duodenal villous pattern in celiac disease. 158
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 158
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study. 157
Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota 156
A) Reliability of the "immersion technique" during routine upper endoscopy for detection of abnormalities of duodenal villi in patients with dyspepsia. 155
The role of diet on gut microbiota composition 155
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 154
A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. 146
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 146
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 137
Diagnostic and therapeutic impact of double-balloon enteroscopy (DBE) in a series of 100 patients with suspected small bowel diseases 135
. Adverse reactions to food: allergies and intolerances. 134
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 133
-Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. 132
Can chronic gastritis cause an increase in fecal calprotectin concentrations? 132
Dramatic improvement of parkinsonian symptoms after gluten-free diet introduction in a patient with silent celiac disease 132
Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes 131
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication 131
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 131
Can chronic gastritis cause increase of fecal calprotectin concentrations? 130
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 130
Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns 129
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study 129
Celiac disease: what's new about it? 127
(gc)Association of laryngeal cancer with previous gastric resection. 126
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. 125
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns. 125
A) High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. 124
Fecal microbiota transplantation: Past, present and future perspectives 124
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. 121
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 121
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 120
-Double-balloon enteroscopy for diagnosis of a Meckel's diverticulum in a patient with GI bleeding of obscure origin 119
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 119
[Helicobacter pylori infection: from gastric to systemic disease] 117
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 117
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 116
Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy 116
gc) Tired legs a gut diagnosis 115
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 114
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 114
A) Association of laryngeal cancer with previous gastric resection 113
-Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth 113
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response 111
-Accuracy of laryngeal examination during upper gastrointestinal endoscopy for premalignancy screening: prospective study in patients with and without reflux symptoms. 110
(gc) Direct visualization of intestinal villi by high-resolution magnifying upper endoscopy: a validation study 109
Faecal calprotectin concentrations in untreated coeliac patients 108
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders 108
Levofloxacin based regimens for the eradication of Helicobacter pylori 107
Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment 107
Classification of malabsorption syndromes. 107
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. 107
gastroesophageal reflux disease: facts and uncertaines 106
A) Gastric surgery as a long-term risk factor for malignant lesions of the larynx. 106
ag) Fecal calprotectin in first-degree relatives of patients with ulcerative colitis. 106
Celiac disease and chronic urticaria resolution: a case report. 106
Reflux symptoms in wind instrument players. 105
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 105
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 104
Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection 103
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 102
Prophylactic aspirin therapy does not increase faecal calprotectin concentrations. 101
Moderately Severe Acute Pancreatitis Associated With Riluzole 101
Increased CD4(+)CD25(+)Foxp3(+) T Cells in Peripheral Blood of Celiac Disease Patients: Correlation with Dietary Treatment. 100
Gluten-related Recurrent Peripheral Facial Palsy 100
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 100
Microscopic colitis 100
. Quick test: a new test for the diagnosis of duodenal hypolactasia. 99
Fecal calprotectin in first-degree relatives of patients with ulcerative colitis 99
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 99
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 98
Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. 97
Link between Helicobacter pylori infection and iron-deficiency anaemia in patients with coeliac disease 97
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study 97
An Attempt of Specific Desensitizing Treatment with Gliadin in Coleliac Disease 97
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. 97
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 97
Therapeutic modulation of gut microbiota: current clinical applications and future perspectives. 96
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 94
Role of N-acetyl-cisteine in the treatment of H. pylori 93
Totale 14.120
Categoria #
all - tutte 95.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.133


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.476 0 0 0 0 0 0 425 129 209 202 310 201
2020/20212.100 113 235 52 192 269 170 230 54 233 91 394 67
2021/20222.089 117 184 57 129 130 89 39 336 97 95 387 429
2022/20234.881 627 658 365 732 320 599 247 386 596 94 159 98
2023/20242.633 133 702 87 172 118 318 175 95 69 156 321 287
2024/20251.628 148 198 468 167 455 186 6 0 0 0 0 0
Totale 22.953